open access

Vol 9, No 1 (2005)
Prace oryginalne
Published online: 2005-02-04
Get Citation

The assessment of adiponectin in patients with acute coronary disease

Anna Miczke, Wiesław Bryl, Paweł Bogdański, Maciej Cymerys, Monika Szulińska, Magdalena Łuczak, Danuta Pupek-Musialik, Olga Trojnarska, Stefan Grajek
Nadciśnienie tętnicze 2005;9(1):31-36.

open access

Vol 9, No 1 (2005)
Prace oryginalne
Published online: 2005-02-04

Abstract

Background Adiponectin (APM1), a protein produced in adipose tissue, takes part in pathogenesis of insulin resistance. Studies have proved also the role of APM1 in atherogenesis. Antiatherogenic properties of APM1 are associated with inhibitory effect of APM1 on adhesion molecules: VCAM-1, E-selectin, ICAM-1. APM1 increases also endothelial production of nitric oxide and inhibits proliferation of vascular smooth muscle cells. Plasma adiponectin concentrations were significantly lower in patients with coronary artery disease (CAD) than those in age- and body mass index-adjusted control subjects.
Material and methods The study included 35 patients with CAD (age 56.3 ± 10.1, BMI 27.2 ± 4.3, WHR 0.95 ± ± 0.07). All subjects underwent coronary angiography. The patients with diabetes mellitus (t. 1 and 2), renal failure and other chronic diseases were not included into the study. All patients underwent a medical examination. ECG, lipid profile, necrosis enzymes were also determined. Adiponectin was measured by RIA (Linco Research). Taking into account the anamnesis, ECG and enzymes the study population was divided into 2 groups: 1 — acute coronary syndrome (20 patients) and 2 — stable angina (15 patients). There was a control group of 10 healthly subjects.
Results Both groups were matched by age, BMI, WHR, body fat percentage and lipid profile. Plasma adiponectin concentration was significantly lower in group with acute coronary syndrome (26.2 ± 13.3 vs. 34.9 ± 10.5 μg/ml,p < 0.05). In both examined group the APM1 concentration was lower than in the control group. In the whole group there was a negative correlation between APM1 and BMI, WHR and TAG-triacyloglicerol.
Conclusions The patients with acute coronary syndrome have lower adiponectin levels than those with stable angina. APM1 is closely associated with other cardiac risk factors (BMI, WHR, TAG).

Abstract

Background Adiponectin (APM1), a protein produced in adipose tissue, takes part in pathogenesis of insulin resistance. Studies have proved also the role of APM1 in atherogenesis. Antiatherogenic properties of APM1 are associated with inhibitory effect of APM1 on adhesion molecules: VCAM-1, E-selectin, ICAM-1. APM1 increases also endothelial production of nitric oxide and inhibits proliferation of vascular smooth muscle cells. Plasma adiponectin concentrations were significantly lower in patients with coronary artery disease (CAD) than those in age- and body mass index-adjusted control subjects.
Material and methods The study included 35 patients with CAD (age 56.3 ± 10.1, BMI 27.2 ± 4.3, WHR 0.95 ± ± 0.07). All subjects underwent coronary angiography. The patients with diabetes mellitus (t. 1 and 2), renal failure and other chronic diseases were not included into the study. All patients underwent a medical examination. ECG, lipid profile, necrosis enzymes were also determined. Adiponectin was measured by RIA (Linco Research). Taking into account the anamnesis, ECG and enzymes the study population was divided into 2 groups: 1 — acute coronary syndrome (20 patients) and 2 — stable angina (15 patients). There was a control group of 10 healthly subjects.
Results Both groups were matched by age, BMI, WHR, body fat percentage and lipid profile. Plasma adiponectin concentration was significantly lower in group with acute coronary syndrome (26.2 ± 13.3 vs. 34.9 ± 10.5 μg/ml,p < 0.05). In both examined group the APM1 concentration was lower than in the control group. In the whole group there was a negative correlation between APM1 and BMI, WHR and TAG-triacyloglicerol.
Conclusions The patients with acute coronary syndrome have lower adiponectin levels than those with stable angina. APM1 is closely associated with other cardiac risk factors (BMI, WHR, TAG).
Get Citation

Keywords

adiponectin; coronary artery disease; cardiac risk; obesity

About this article
Title

The assessment of adiponectin in patients with acute coronary disease

Journal

Arterial Hypertension

Issue

Vol 9, No 1 (2005)

Pages

31-36

Published online

2005-02-04

Bibliographic record

Nadciśnienie tętnicze 2005;9(1):31-36.

Keywords

adiponectin
coronary artery disease
cardiac risk
obesity

Authors

Anna Miczke
Wiesław Bryl
Paweł Bogdański
Maciej Cymerys
Monika Szulińska
Magdalena Łuczak
Danuta Pupek-Musialik
Olga Trojnarska
Stefan Grajek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl